Andre Esteva has been selected for the TIME 100 Health list of the world’s most influential people in health
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, shared a post by Andre Esteva, at
“This is so well deserved, Andre Esteva and Team Artera AI. I am grateful to serve as a Board Advisor, and most importantly for all that you are doing to match prostate cancer patients to the right therapy, the first time. This is precision medicine in action. Well done, Time Inc.”
Quoting Andre Esteva‘s post:
“Thank you TIME for selecting me for the TIME 100 Health list of the world’s most influential people in health.
It’s been a privilege to found and lead Artera AI – the work we are doing will save so many lives. Already our prostate cancer test, which helps identify which therapies patients would most benefit from, has been adopted by ~20% of prostate cancer clinicians just 5 quarters from launch.
We are in the NCCN Guidelines for the treatment of prostate cancer (National Comprehensive Cancer Network (NCCN)), reimbursed by Medicare (Centers for Medicare and Medicaid Services), covered by dozens of private payers (including Anthem, Inc.), and scaling in the US and abroad.
If you are attending this year’s American Society of Clinical Oncology (ASCO) meeting, drop by and see our various presentations on our work developing predictive AI tests for both prostate and breast cancer.Artera and I wouldn’t be here without the support of our many wonderful investors and advisors. So much gratitude.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023